Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Omlyclo (omalizumab-igec), an Interchangeable Biosimilar to Xolair
Celltrion today announced the U.S. Food and Drug Administration (FDA) approved Omlyclo® (omalizumab-igec) as the first and only biosimilar...
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease
scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through...
FDA Approves Encelto (revakinagene taroretcel-lwey) for the Treatment of Macular Telangiectasia Type 2 (MacTel)
(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc., a private biotech company focused on developing transformative therapies for chronic eye diseases, announced...
Red Wine Protects Against Cancer? Maybe Not
Red wine has been thought to potentially offer protection against cancer, given its high levels of the anti-inflammatory antioxidant resveratrol.But there’s...
Weed Use During Pregnancy Triples Risk Of Behavioral Problems In Kids
Some women turn to weed during pregnancy to help deal with common issues like nausea, sleep problem and stress.Unfortunately, they could be endangering...
Concussion Damage Lingers In Athletes' Brains Up To A Year
Concussion damage could linger in an athlete’s brain for at least a year, long after they’ve rejoined their sport, a new study says.Concussed college...
Turning Off TV Better For Heart Health Of Folks Predisposed To Diabetes
People with a higher genetic risk for type 2 diabetes also have a higher risk of heart attack, stroke and other heart-related diseases.But controlling...
ViiV Healthcare’s Investigational Broadly Neutralising Antibody - N6LS - Successfully Maintains Viral Suppression in Long-Acting Treatment of HIV
London, 12 March 2025 – ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today...
Tecovirimat is Safe But Ineffective as Treatment for Clade II Mpox
The antiviral drug tecovirimat used without other antivirals did not reduce the time to clinical resolution of clade II mpox lesions or improve pain control...
Bronchodilator Responsiveness Positivity More Likely in Morning
Patients are more likely to have positive bronchodilator responsiveness in the morning and in winter months, according to a study published online March...
AAOS: Header Ban Linked to Decrease in Soccer-Linked Concussions in Children
Introduction of the United States Soccer Federation (USSF) header ban for athletes aged 10 years and younger in 2015 was associated with a reduction in...
Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk
Medium and high type 2 diabetes (T2D) genetic risks are not associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD) when television...
No Weight Loss Benefit Seen for Neoadjuvant Semaglutide Before Weight Loss Surgery
Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to a research letter published...
Voluntary Lot Withdrawals of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) Due to Increased Reports of Allergic/Hypersensitivity Reactions
As a precautionary measure, the following lots of Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC) have been voluntarily withdrawn...
Butter Is A Deadly Delight, Study Says
It’s a cook’s maxim that everything’s better with butter. Except your health, a new study suggests. People who eat loads of butter...
Recently Added
Recently added consumer and prescribing information: Opdivo Qvantig, Alyftrek, Crenessity, Ensacove, Steqeyma, Yesintek, Revuforj, Danziten, Aucatzyl, Emrosi
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Omlyclo Omlyclo (omalizumab-igec) is an anti-IgE antibody interchangeable biosimilar to Xolair for the treatment of asthma, chronic rhinosinusitis...
- Encelto Encelto (revakinagene taroretcel-lwey) is an allogeneic encapsulated cell-based gene therapy indicated for the treatment of adults with...
- Osenvelt Osenvelt (denosumab-bmwo) is a RANK ligand (RANKL) inhibitor biosimilar to Xgeva (denosumab) for use in the prevention of skeletal-related...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...